327 related articles for article (PubMed ID: 10550572)
1. Hepatic arterial infusion chemotherapy for unresectable confined liver metastases: prediction of systemic toxicity with the application of a scintigraphic and pharmacokinetic approach.
Pelosi E; Bar F; Battista S; Bellò M; Bucchi MC; Alabiso O; Molino G; Bisi G
Cancer Chemother Pharmacol; 1999; 44(6):505-10. PubMed ID: 10550572
[TBL] [Abstract][Full Text] [Related]
2. Sorbitol removal by the metastatic liver: a predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases.
Bar F; Battista S; Bucchi MC; Zanon C; Grosso M; Alabiso O; Miraglia S; Cappello N; Gariboldi A; Molino G
J Hepatol; 1999 Jun; 30(6):1112-8. PubMed ID: 10406191
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m labelled macroaggregated albumin arterial catheter perfusion scintigraphy: prediction of gastrointestinal toxicity in hepatic arterial chemotherapy.
Pelosi E; Masaneo I; Clara R; Valetto MR; Bellò M; Zanon C; Chiappino I; Grosso M; Mussa A; Bisi G
Eur J Nucl Med; 2000 Jun; 27(6):668-75. PubMed ID: 10901453
[TBL] [Abstract][Full Text] [Related]
4. Fusion imaging using a hybrid SPECT-CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients.
Denecke T; Hildebrandt B; Lehmkuhl L; Peters N; Nicolaou A; Pech M; Riess H; Ricke J; Felix R; Amthauer H
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1003-10. PubMed ID: 15846488
[TBL] [Abstract][Full Text] [Related]
5. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
6. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.
Kingham TP; D'Angelica M; Kemeny NE
J Surg Oncol; 2010 Dec; 102(8):988-95. PubMed ID: 21166003
[TBL] [Abstract][Full Text] [Related]
7. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
8. [Significance of radionuclide examination in hepatic arterial infusion chemotherapy using implantable reservoir].
Yasuda S; Noto T; Ikeda M; Mukai M; Horie O; Ishida H; Kubo H; Nakazaki H; Tajima T; Mitomi T
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1940-3. PubMed ID: 1877836
[TBL] [Abstract][Full Text] [Related]
9. Deriving the intrahepatic arteriovenous shunt rate from CT images and biochemical data instead of from arterial perfusion scintigraphy in hepatic arterial infusion chemotherapy.
Ozaki T; Seki H; Shiina M
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):946-51. PubMed ID: 19484290
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
[TBL] [Abstract][Full Text] [Related]
11. Misperfusion of the liver during hepatic artery infusion chemotherapy: value of preoperative angiography and postoperative pump scintigraphy.
Civelek AC; Sitzmann JV; Chin BB; Venbrux A; Wagner HN; Grochow LB
AJR Am J Roentgenol; 1993 Apr; 160(4):865-70. PubMed ID: 8456683
[TBL] [Abstract][Full Text] [Related]
12. Arterial perfusion abnormalities of the liver after hepatic arterial infusion chemotherapy and their correlation with changes in the metastases: evaluation with CT and angiography.
Roth J; Wallner B; Safi F
AJR Am J Roentgenol; 1989 Oct; 153(4):751-4. PubMed ID: 2672735
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fusion imaging using a combined SPECT/CT system and intra-arterial CT: assessment of drug distribution by an implantable port system in patients undergoing hepatic arterial infusion chemotherapy.
Ikeda O; Kusunoki S; Nakaura T; Shiraishi S; Kawanaka K; Tomiguchi S; Yamashita Y; Takamori H; Chikamoto A; Kanemitsu K
Cardiovasc Intervent Radiol; 2006; 29(3):371-9. PubMed ID: 16502168
[TBL] [Abstract][Full Text] [Related]
14. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
15. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
[TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.
Homsi J; Garrett CR
Cancer Control; 2006 Jan; 13(1):42-7. PubMed ID: 16508625
[TBL] [Abstract][Full Text] [Related]
18. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin and calcium heparin in thrombosis prophylaxis in patients with percutaneous arterial and venous ports for colorectal liver metastases.
Zanon C; Bortolini M; Chiappino I
Tumori; 2005; 91(6):477-80. PubMed ID: 16457145
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
